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Abstract 8 
The solubility of telmisartan (form A) in nine organic solvents (chloroform, 9 
dichloromethane, ethanol, toluene, benzene, 2-propanol, ethyl acetate, methanol and 10 
acetone) was determined by laser monitoring technique at different temperatures 11 
(from 277.85 to 338.35 K). The solubility of telmisartan (form A) in all the nine 12 
solvents increased with temperature and the rates of solubility also increased with 13 
temperature except in chloroform and dichloromethane solvent. The molar fraction 14 
solubility in chloroform was higher than that in dichloromethane, which were both 15 
one order of magnitude higher than that in other seven solvents at the range of 16 
experimental temperatures. The solubility data were correlated with the modified 17 
Apelblat equation and λ h equation, respectively. The results showed that the λ h 18 
equation was in better agreement with the experimental data than the Apelblat 19 
equation. The relative root mean square deviations (σ) of the λ h equation were in the 20 
range from 0.004 % to 0.45%. The uncertainty of the fit parameters also showed that λ 21 
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h equation was much better than Apelblat equation. The dissolution enthalpy, entropy 1 
and Gibbs free energy of telmisartan (form A) in these solvents were estimated by the 2 
Van’t Hoff equation and the Gibbs equation. The melting point and the fusion 3 
enthalpy of telmisartan (form A) were determined by differential scanning calorimetry 4 
(DSC). 5 
Keywords: Telmisartan; Solubility; Apelblat equation; λh Equation; Solution 6 
thermodynamic properties 7 
1. Introduction 8 
Telmisartan(2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-9 
benzodiazol-1-yl]methyl}phenyl)benzoic acid, CAS No.: 144701-48-4, Fig. 1) is a 10 
white or off-white crystalline power, which has been used in clinic for the treatment 11 
of hypertension as the orally active angiotensin II receptor antagonist (ARB) [1]. An 12 
increasing use of telmisartan as the active component in conventional tablets for the 13 
treatment of hypertension has been observed because of its efficacious 14 
antihypertensive effects and fewer adverse effects [2]. Additionally, telmisartan has 15 
also been proved to be effective against cardiovascular diseases and diabetes [3]. 16 
Among already reported polymorphic crystalline forms of telmisartan (forms A, B 17 
and C) [4], form A is generally employed in the manufacturing of tablets due to its 18 
thermodynamic stability at room temperature and the ability of crystallization from 19 
various solvents such as ethanol, chloroform and acetic acid solution [5, 6].  20 
The solid-liquid equilibrium data are important in many fields of chemical 21 
engineering such as crystallization and extraction. The difference between the 22 
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concentrations of a super-saturated solution and the saturated solution is the key 1 
influential factor for nucleation, crystal growth and agglomeration during the 2 
crystallization process, on which the polymorph, the morphology and the size 3 
distribution of the crystals are dependent. In order to control the crystallization 4 
process, precise and adequate solubility data is indispensable. Until now, very few 5 
experimental data regarding the solubility of telmisartan in alkalized conditions, 6 
chloroform, and ethanol has been reported at room temperature [7, 8]. The lack of the 7 
data about the solubility of telmisartan (form A) in pure organic solvents at sufficient 8 
temperature range has hindered the manufacturing and purifying processes.  9 
In this work, the solubility of telmisartan (form A) in nine organic solvents including 10 
chloroform, dichloromethane, ethanol, toluene, benzene, 2-propanol, ethyl acetate, 11 
methanol and acetone was determined with the temperature ranging from 277.85 to 12 
338.35 K at atmospheric pressure by a synthetic method of a laser monitoring 13 
observation technique. The solubility data of telmisartan in these organic solvents is 14 
correlated by the modified Apelblat equation and the λ h equation. The 15 
thermodynamic properties (e.g. enthalpy, entropy and Gibbs free energy) of 16 
dissolution process of telmisartan in these solvents were calculated using regression 17 
equations, i.e. Van’t Hoff equation and Gibbs equation.  18 
2. Experimental Section 19 
2.1 Chemicals Used 20 
Telmisartan (C33H30N4O2, molecular weight 514.62) was purchased from Zhengzhou 21 
Chuangyao Technology Co.Ltd., China. The raw material is a white crystalline 22 
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powder and the polymorph is form A, measured by XRD. Its purity was 99.3% 1 
(determined by HPLC, Model TM 2130, China) after recrystallization, and the 2 
telmisartan was put in a desiccator and used without further treatment. The 3 
chloroform, dichloromethane, methanol and acetone were purchased from Luoyang 4 
Haohua Chemical Reagent Co., China. The ethanol, toluene, benzene, 2-propanol and 5 
ethyl acetate were purchased from Tianjin Kewei Chemical Reagent Co., China. All 6 
the organic solvents used for the solubility determination were analytical grade 7 
reagents with mass purities higher than 99.5 %. The detailed information of the 8 
materials used in the experiments is listed in Table 1.  9 
2.2 Apparatus and Procedure.  10 
The solubility measuring apparatus is shown in Figure 2. The solubility was measured 11 
using the laser monitoring technique and the synthetic method at a constant 12 
temperature [9-14], which have been reported to have similar measuring principle and 13 
setup [15].  14 
The laser system (JS2-1009016, Beijing, China) was made up of a laser generator, a 15 
digital light-intensity display, and a photoelectric transformer. The solutions were 16 
prepared in a 50 mL or 100 mL jacketed glass vessel, and the temperature of the 17 
solution inside the glass vessel was controlled by circulating water from a 18 
thermostatic water-circulator bath with a digital thermoelectric controller (type 19 
HH-601A, China). Temperatures were measured by using a mercury-in-glass 20 
thermometer with an accuracy of ±0.1K. The temperatures were only recorded to the 21 
nearest ±0.1 °C and then converted to the Kelvin scale by adding 273.15. The solution 22 
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was continuously stirred with a magnetic stir bar. A condenser was connected to the 1 
vessel to avoid the loss of solvent. Masses of solvents and solute were weighed using 2 
an analytical balance (type Mettler Toledo AB204-N, Switzerland) with an accuracy 3 
of 0.0001 g. 4 
Initially, the pure solvent (about 50 g, or about 100g at lower temperature) was 5 
prepared in the jacketed vessel until the temperature varied within 0.05 K. Then 6 
predetermined known mass of telmisartan (form A) was added into the stirred solution. 7 
The amount of solvents was of a little excess. An additional solute of known mass 8 
(about 10 mg) was added into the stirred solution after being agitated at a fixed 9 
temperature for 1 h. This procedure was repeated until the last portion of the solute 10 
cannot be dissolved completely within the interval of addition of 30 min. The solute 11 
mass consumed during the solubility determination was recorded (included the last 12 
portion).The dissolution of the solute was monitored by a laser beam. When the solute 13 
dissolved completely, the solution was clear, and the laser intensity penetrated through 14 
the solution reached its maximum. When the laser intensity did not exceed 90% of the 15 
maximum, the solute was believed not to be dissolved completely. The amount of 16 
solute leading to the laser intensity decrease 10% from the maximum is less than 1.0 17 
mg. The saturated mole fraction solubility of telmisartan form A (x1) in each solvent 18 
was calculated using the following equation (Eq. 1): 19 
 20 
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where M and m represent mole mass and mass, respectively, and subscripts 1 and 2 1 
represent solute telmisartan (form A) and solvents, respectively. The same solubility 2 
measurement was conducted twice. The uncertainty of the experimental solubility 3 
values was due to the weighing procedure, temperature measurements, and 4 
temperature variation of the water bath.  5 
The melting point and the molar enthalpy of fusion of telmisartan form A were 6 
determined in triplicate by the differential scanning calorimetry (Metter Toledo DSC 7 
822. Thermal curves were recorded with a heating rate of 10.0 Kmin-1 with the 8 
temperature ranging from 298 to 623 K under a dry nitrogen purge (80 mlmin-1). The 9 
masses of the telmisartan form A sample used in the different runs performed were 10 
taken practically identical (~ 4.0 mg). The peak temperature was taken as the melting 11 
point. The melting point and the molar enthalpy of fusion of telmisartan form A were 12 
measured by DSC and repeated three times. 13 
3. Results and Discussions 14 
3.1 The XRD and DSC of telmisartan 15 
Fig. 3a (top) is the X-ray powder diffraction (XRD) data of telmisartan, the pattern is 16 
identical with the XRD pattern of telmisartan form A (Fig. 3a, bottom, CCDC 17 
reference XUYH0001). Fig. 3b shows the DSC of telmisartan form A. The average 18 
melting point and melting enthalpy with uncertainty is 542.42 ±0.20 K and 19 
-105.34±8.54 Jg-1, respectively, as shown in Fig. 3b.The melting point result is 20 
consistent with the literature reported value 542 oC by J.Park [8]. 21 
3.2 Solubility  22 
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The variation of solubility of telmisartan (form A) in different solvents with 1 
temperature is presented in Table 2 and Fig. 4, showing that the solubility of 2 
telmisartan (form A) increased with the increasing temperature in all the organic 3 
solvents. The solubility values in chloroform and dichloromethane were much higher 4 
than those in the other seven solvents. This phenomenon may result from the 5 
solute-solvent interaction, which plays an important role in the dissolution process of 6 
telmisartan in chloroform and dichloromethane. During the dissolution process, three 7 
factors, namely the solute-solute, solute-solvent and solvent-solvent interaction, can 8 
affect the solubility. The solubility is generally higher when the solute-solvent 9 
interaction plays a main role. The mole fraction solubility of telmisartan (form A) 10 
decreased in the following order: chloroform > dichloromethane > benzene> 11 
methanol > toluene > acetone > ethanol > ethyl acetate > 2-propanol. For alcoholic 12 
solvents, the solubility increased with the increase of the solvent polarity. The 13 
dielectric constants of methanol, ethanol and 2-propanol were 33.6, 24.3 and 19.92 at 14 
25 oC, respectively. The solubility in chloroform  was much higher than that in 15 
dichloromethane and the solubility in benzene is higher than that in toluene. The 16 
polarity of chloroform and benzene, respectively, is higher than that of 17 
dichloromethane and toluene, respectively. For the similar solvents such as alcoholic 18 
solvents, the polarity directly correlated with the solubility.  19 
In order to quantify the importance of the different interactions to the changes in 20 
solubility. We use the linear free energy relationship [16] (Equation(2), based on 21 
Abraham model, the subscript-zero indicates that c = 0 in log 22 
P=c+eE+sS+aA+bB+vV ),  23 
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               (2) 1 
where logP is the solvent/water partition, (e, s, a, b, v) are the solvent coefficients, and 2 
(E, S, A, B, V) are the solute descriptors: E is the solute excess molar refractivity, S is 3 
the solute dipolarity/polarizability, A and B are the overall or summation hydrogen 4 
bond acidity and basicity, and V is the McGowan characteristic volume. The solvent 5 
coefficients were from reference 16 and were list in table 3.The solute descriptors 6 
were obtained through fit the data at about 298K(R2=0.9799) and the E=0.71, S=1.35, 7 
A=-0.16, B=1.33,V=1.27, respectively. It seems that the hydrogen bond basicity play 8 
an important role in the interaction. Also, according to the structure of the solute, there 9 
has 5sites that can act as hydrogen bond acceptors (4 Ns and the COO of the acid 10 
group) and one hydrogen bond donating site. When the polarity of the solvents (for 11 
similar solvents) is higher, it is much easier to form the strong solute-solvent 12 
interaction. Therefore, the solubility will increase. The highest solubility in 13 
chloroform maybe attribute to the strong hydrogen bond between telmisartan and 14 
chloroform. The electron density around chloroform is higher and also the steric 15 
hindrance of the chloroform is smaller, so it is easier to form hydrogen bond than 16 
other solvent. The solubility in benzene is higher maybe attribute to the aromatic ring 17 
in the structure of temisartan, consistent with the rule of like dissolves like. For the 18 
solubility in toluene is lower than in benzene maybe because the steric hindrance of 19 
the benzene. 20 
3.3 Correlation of Measured Solubility  21 
Fig. 4 shows the trend of the solubility of telmisartan (form A) in these organic 22 
solvents at the temperature from 277.85 to 338.35 K. The mole fraction solubility data 23 
was correlated by the Apelblat’s empirical equation [17]: 24 
lnx1=A+ B / T+ C ln (T)           (3) 25 
where x1 is the mole fraction solubility of telmisartan, A, B, and C are all empirical 26 
constants determined by least square analysis, and T is the absolute solution 27 
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temperature. Equation (3) of this revised version will be obtained by integration of 1 
van’t Hoff’s equation when ∆slnCop, m =0 is assumed and the solutions are ideal. 2 
Correlation parameters (A, B, and C) of Eq. 3 for telmisartan (form A) in different 3 
solvents are listed in Table 4 as well as the relative root-mean square deviation (σ), 4 
which shows the derivation between the estimated solubility value by equation 3 with 5 
the experimental solubility result at each temperature: 6 
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where N is the number of experimental solubility data, calc
1,
x
i
 is the solubility 8 
estimated by Eq 3, and exp
1,
x
i
 is the experimental solubility. Fig. 4 shows that the 9 
calculated solubility is consistent with the experimental results in all the solvents. 10 
Also, according to the values of relative root-mean square deviation (σ) in Table 4, the 11 
Apelblat model (Eq.3) is well fitted to the measured solubility data of telmisartan 12 
(form A) in the selected solvents, with the relative root mean square deviation σ 13 
changed from 1.19 % to 7.61%.  14 
To evaluate fitting equation, the random errors (uncertainties) of the fit parameters 15 
also were calculated. The uncertainties value is the standard error (got from the 16 
integration of the equation) divided by the parameter value. The uncertainties values 17 
for the 3 parameters (A, B and C) were showed in table 4. It can be seen that many of 18 
the uncertainty of the 3 parameters exceed the values, such as the case of telmisartan 19 
in methanol the uncertainties of the A, B and C amount to 1.779, 2.828 and 1.583 of 20 
their values, respectively. Also, the uncertainty of some parameters in other 4 solvents 21 
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exceed the parameters values. Thus the Apelblat equation is not well fitted to the 1 
measured solubility data of telmisartan (form A) regardless of the higher relative root 2 
mean square deviation. The Apelblat eqution contributes only very uncertain values to 3 
the thermodynamic basis of these systems, and its use as fitting equation is 4 
questionable. 5 
The solubility data can also be described by the λ h equation (Eq.5) with two 6 
parameters λ and h [18]: 7 
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Where T represents the system absolute temperature, Tm is the melting temperature of 10 
telmisartan (form A) in Kelvin, x1 is the mole fraction solubility of telmisartan, λ and h 11 
are model parameters determined by correlating the experimental data. These 12 
correlations can also be evaluated with relative root-mean square deviation (σ, Eq.4). 13 
The correlation results of λh equation are presented in Table 5. The value of the 14 
relative root-mean square deviation σ (with the range from 0.004 % to 0.45%) in the 15 
λh equation is better than those in the modified Apelblat equation for this system. Also 16 
the uncertainties of the 2 parameters were calculated and listed in Table 5. It can be 17 
seen that the uncertainties of the λ amount to from 6.2% to 30.8% of its values. And 18 
for the h, the values were from 3.7% to 25.3%. Compare with the uncertainties of the 19 
Apelblat equation. The λh equation is much better than the modified Apelblat equation 20 
for this system. The parameter λ is a measure of non-ideality of the saturated solution. 21 
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The values of λ are much smaller than 1 (the λ is 1 when the solution is ideal) in this 1 
study, so these solution all deviated from the ideal solution. 2 
3.4 Thermodynamic Functions of Solution 3 
For the dilute or ideal solutions, the modified Van’t Hoff equation relates the 4 
logarithm of mole fraction of the solute as a linear function of the reciprocal to the 5 
absolute temperature by the following equation (Eq. 6) [19, 20, 21, 22]: 6 
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Equation (6) is Van’t Hoff’s equation integrated assuming omsInH
 is constant within 8 
the temperature range investigated, this equivalent to assuming o m,sIn pC =0. Where x1 9 
is the mole fraction solubility, R is the universal gas constant, T is the absolute 10 
temperature, and omsInH  and 
o
msInS  are not the true enthalpy and entropy of 11 
solution but are apparent values because activity coefficients are assumed to be unity. 12 
Equation (6) shows that the natural logarithm of mole fraction of the solute is a linear 13 
function of the reciprocal of the absolute temperature. Thus, the values of enthalpy 14 
o
msIn H  were obtained from the slope of the plot of lnx1 versus 1/T, and the values of 15 
entropy omsInS  were calculated from the intersection of the regression of lnx1 versus 16 
1/T as shown in Fig. 5. The uncertainty of the omsIn H and 
o
msInS  also were calculated 17 
and listed in Table 6. The uncertainties of 
o
msIn H  amount to 1.4% (in 18 
dichloromethane) to 8.4% (in chloroform) of its values, which were acceptable. But 19 
the uncertainties of 
o
msInS  were from 9.5% (in dichloromethane) to 54.7% (in Ethyl 20 
acetate) except in the Acetone, which has a much higher uncertainty for
o
msInS . The 21 
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Gibbs free energy solution can be obtained from the following equation (Eq. 7) [23]: 1 
0
msInhm
o
msIn
o
msIn STHG                   (7) 2 
Where Thm is the harmonic mean of the experimental temperature, which can be 3 
calculated by Thm= n/ )/1(
1


n
i
iT , n is the number of experiment. The use of harmonic 4 
mean of the temperature was because there are different temperatures when we 5 
measured the solubility and the average temperature is needed when the Gibbs free 6 
energy was calculated. The Thm values, molar dissolution enthalpy, molar dissolution 7 
entropy and the change of Gibbs free energy are shown in Table 6. 8 
In order to compare the relative contributions by enthalpy omsIn H to that by entropy 9 
o
msInS  toward the solution process, Eq. (8) and (9) were used, respectively [20]. 10 
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Where H%  and TS%  are the relative contributions to the Gibbs free energy by 13 
enthalpy and entropy during the solution process, respectively. The values of 14 
H% and TS%  were given in Table 6. From Table 6, it can be established that 1) the 15 
enthalpies of solution omsIn H  are positive in all solvents, indicating that the 16 
dissolution process is always endothermic in these solvents. The entropies of solution 17 
o
msInS  are negative in chloroform and dichloromethane. However, in other solvent 18 
the entropies of solution 
o
msInS  are positive. The positive entropy variation shows 19 
that the entropy of solubilization is unfavorable for solute in solution [24], whereas 20 
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the negative entropy is owing to more ordered structure in solutions [25]. The order 1 
depends on the solvent as well as on the functional groups present in the solute. The 2 
negative entropy change in chloroform and dichloromethane (the chlorine atoms make 3 
the carbon atom easier to attract electrons) may be attributed to the interactions such 4 
as H-bonds between solute and solvent molecules which may display more ordered 5 
structure in solution, that is, the solute-solvent interaction is stronger than the 6 
solvent-solvent interaction in these two solvents. Another reason may be that the 7 
molecular structures of chloroform and dichloromethane are hard to be disrupted [26]. 8 
2) the molar Gibbs free energy of dissolution are positive in all cases, which indicates 9 
that the dissolution process of telmisartan in all these organic solvents is not 10 
spontaneous; 3) all the values of H%  are higher than 69.69%, which indicates that 11 
the change of the enthalpy contributes more to the Gibbs free energy of dissolution of 12 
telmisartan in the these nine organic solvents than the change of the entropy. 13 
3.5 Effect of Solvates or Polymorphism on the Telmisartan Solubility Data.  14 
One possible source of systematic error in this kind of experiment is the 15 
transformation of the solid to a solvate or another polymorph during the experiment. 16 
During the solubility measurement, the temperature was always below 65 oC, the 17 
telmisartan form A was stable. The solubility data can be fitted well by the both the λh 18 
equation and modified Apelblat equation without any inflection points. It is reported 19 
that polymorph of telmisartan was always the form A by cooling crystallization in 20 
some systems [4]. In this study solid telmisartan form A, kept in saturated solution 21 
with these solvents for several hours, consisted still of long, needle-like crystals, 22 
 14 
 
which as determined by XRD  maintained form A. Therefore, the consistent increase 1 
of the solubility value and the determination of solid in slurry by power XRD both 2 
demonstrate that no solvates or the other polymorph appeared during the 3 
measurements. 4 
4. Conclusion 5 
In this work, the solubility of telmisartan (form A) in chloroform, dichloromethane, 6 
ethanol, toluene, benzene, 2-propanol, ethyl acetate, methanol and acetone were 7 
determined by laser monitoring techniques. There is no polymorphic transformation 8 
during the measurement from 277.85 to 338.35 K in these nine organic solvents. The 9 
solubility of telmisartan in chloroform and dichloromethane is much higher than that 10 
in the other seven solvents at the temperature ranging from 277.85 to 338.35 K. The 11 
solubility in these nine organic solvents increased with the increase of temperature, 12 
but the temperature increments were different for different solvents. Based on the 13 
values of the relative root mean square deviation σ and the uncertainties of the 14 
parameters, the solubility of telmisartan in the solvents can be fitted much better with 15 
λh equation than with the modified Apelblat equation. It also indicates that the 16 
correlated equation in this work could provide essential data for purifying and 17 
manufacturing processes of telmisartan in industry.  18 
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Figure 1. Molecular structure of telmisartan 28 
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Figure 2.  Sketch of the apparatus for measurement of the solubility  15 
1-laser generator；2-dissolver；3-condenser；4-magnetic stirrer；5- magnetic stir bar；16 
6-light intensity recorder；7-photoelectric transformer；8-thermostatic water bath； 17 
9-thermometer 18 
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Figure 3. Powder XRD (a) and DSC (b) curve of telmisartan (form A) 1 
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Figure 4. Mole fraction solubility of telmisartan, x1, in different solvents: 10 
(a)☆,chloroform ;◇,dichloromethane ; (b)▲,benzene; ●,methanol ; ★, toluene; △, 11 
 20 
 
acetone; ■, ethanol;□, ethyl acetate ; ○,2-propanol. Curves are data fits using Eq 2 and 1 
the parameters in Table 3. 2 
 3 
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Figure 5. The Van’t Hoff plots of ln x1verse 1/T for telmisartan form A in different 5 
solvents ☆,chloroform ;◇,dichloromethane ; ▲,benzene; ●,methanol ; ★, toluene; 6 
△, acetone; ■, ethanol;□, ethyl acetate ; ○,2-propanol 7 
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Table 1 The Source and Mass Fraction Purity of Chemicals
a
 1 
Materials Source 
Initial Purity 
(mass fraction) 
Chloroform Haohua Chemical Reagents Co. China 99.5% 
Dichloromethane Haohua Chemical Reagents Co.China 99.5% 
Benzene Tianjin Kewei Chemical Reagent Co., China 99.5% 
Methanol Haohua Chemical Reagents Co. China 99.5% 
Toluene Tianjin Kewei Chemical Reagent Co., China 99.5% 
Acetone Haohua Chemical Reagents Co.China 99.5% 
Ethanol Tianjin Kewei Chemical Reagent Co., China 99.7% 
Ethyl acetate Tianjin Kewei Chemical Reagent Co., China 99.5% 
2-Propanol Tianjin Kewei Chemical Reagent Co., China 99.7% 
Telmisartan
b
                    Zhengzhou Chuangyao Technology Co. China 99.0% 
a: All of the solvents were used without further purification. 2 
b: Telmisartan, purified by recrystallization and the purity was 99.3% (determined by HPLC) 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
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 16 
 17 
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Table 2 Mole Fraction Solubilities of Telmisartan (form A), x1, in Chloroform , Dichloromethane, 1 
Benzene, Methanol, Toluene, Acetone, Ethanol, Ethyl acetate, and 2-Propanol.
a
(Experimental pressure 2 
is 101.3 KPa)  3 
T/K 
103 
x1exptl 
105(x1exptl - 
x1calcd ) 
 
T/K 103 x1exptl 
105(x1exptl - 
x1calcd ) 
   Chloroform    
278.75 5.33 4  303.95 7.47 -4 
289.45 6.24 -14 308.35 7.71 -5 
296.95 7.01 4 313.15 7.99 2 
298.15 7.25 13    
   Dichloromethane    
278.35 1.50 5  305.25 2.46 -2 
286.55 1.77 0  308.35 2.61 2 
293.95 2.05 -2  311.75 2.72 3 
298.05 2.16 -7     
   Benzene    
278.55 0.0695 -0.59  316.15 0.289 -0.2 
288.45 0.111 0  324.35 0.361 -1.2 
299.85 0.163 -0.6  333.35 0.488 0.5 
307.25 0.236 1.8     
   Methanol    
278.45 0.0603 -0.34  313.25 0.186 -0.2 
288.55 0.0890 0.15  324.85 0.271 0.2 
299.85 0.132 0.7  330.05 0.315 0 
307.35 0.153 -0.4     
   Toluene    
278.65 0.0355 -0.56  316.75 0.169 0.3 
288.45 0.0608 0.12  325.85 0.225 -0.4 
300.05 0.0840 -0.75  334.55 0.307 0 
 23 
 
306.35 0.125 1.0     
   Acetone    
278.55 0.0442 0.16  308.75 0.112 -0.2 
287.45 0.0571 -0.04  316.25 0.141 -0.3 
294.55 0.0776 0.50  325.75 0.193 0.3 
303.85 0.0945 -0.33     
   Ethanol     
277.85 0.0306 0.03  313.45 0.117 0.3 
288.45 0.0457 0.14  329.75 0.219 0.1 
298.45 0.0633 -0.09  333.65 0.255 -0.1 
308.35 0.0900 -0.37     
   Ethyl acetate    
283.65 0.0247 -0.35  317.95 0.0883 -0.19 
293.35 0.0417 0.16  329.45 0.123 -0.40 
303.65 0.0590 0.20  333.65 0.148 0.3 
305.35 0.0626 0.23     
   2-Propanol    
288.45 0.0155 0  321.55 0.0741 0.06 
298.05 0.0277 0.32  329.55 0.106 0 
309.55 0.0410 -0.11  338.35 0.157 0 
316.55 0.0562 -0.22     
a:the temperature accuracy is 0.1 K, analytical balance accuracy is 0.0001 mg 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
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Table 3 Solvent Coefficients in Equation 2 for Different Solvents 1 
Solvent e0 s0 a0 b0 v0 
chloroform 0.089 -0.358 -3.051 -3.538 4.493 
dichloromethane 0.076 -0.112 -2.957 -4.13 4.488 
benzene 0.452 -0.554 -2.964 -4.643 4.564 
methanol 0.312 -0.649 0.33 -3.355 3.691 
toluene 0.412 -0.615 -2.962 -4.764 4.589 
acetone 0.287 -0.047 -0.509 -4.792 4.103 
ethanol 0.453 -0.983 0.396 -3.623 3.971 
ethyl acetate 0.195 -0.068 -0.924 -4.571 4.152 
2-propanol 0.355 -1.026 0.438 -3.839 4.048 
 2 
 3 
Table 4 Parameters of Apelblat Equation, Eq. 3, for Telmisartan (Form A) in Different Solvents 4 
Solvent Aa δA1 B δB2 C δC3 102σb 
Chloroform 223.48 0.293 -10665.53 0.251 -32.60 0.279 1.19 
Dichloromethane 222.23 1.11 -11129.61 0.478 -32.31 0.928 1.89 
Benzene 17.92 0.667 -3565.35 0.447 -1.37 0.756 4.75 
Methanol -101.30 1.78 2054.61 2.82 16.19 1.58 3.26 
Toluene -88.12 1.87 1042.74 0.898 14.42 2.61 7.61 
Acetone -57.93 0.689 41.26 1.47 9.70 0.69 3.30 
Ethanol  -208.88 0.185 6329.04 0.257 32.45 0.174 2.26 
Ethyl acetate -19.38 0.593 -1866.93 0.429 3.97 0.611 6.18 
2-Propanol -128.81 0.894 1960.85 1.76 20.80 0.74 4.78 
a  A, B and C are parameters of Eq. 3 5 
b  Calculated by Eq. 4 6 
1 random error (uncertainty) of A, δA=standard error/ |A| 7 
2 random error (uncertainty) of B, δB=standard error/|B| 8 
3 random error(uncertainty) of C, δC=standard error/ |C| 9 
 25 
 
Table 5 Parameters of λh Equation, Eq. 5, for Telmisartan (Form A) in Different Solvents 1 
Solvent λa δλ
* h δh
#
 10^3σb 
Chloroform 0.00874 29.3 % 61187 12.0 % 0.71 
Dichloromethane 0.01468 6.2 % 92300 3.7 % 1.70 
Benzene 0.01663 18.3 % 185505 15.1 % 1.38 
Methanol 0.00965 11.3 % 302690 8.93 % 0.04 
Toluene 0.01569 28.6 % 220573 23.9 % 1.45 
Acetone 0.00633 15.7 % 456333 12.1 % 0.09 
Ethanol 0.02184 19.1 % 177642 15.5 % 4.53 
Ethyl acetate 0.00474 30.8 % 644998 25.3 % 0.52 
2-Propanol 0.03052 28.4 % 155832 24.2 % 3.19 
a  λ and h are parameters of Eq. 5 2 
b  Calculated by Eq. 4 3 
* random error(uncertainty) of λ, δλ=standard error/ |λ| 4 
# random error(uncertainty) of h, δh=standard error/|h| 5 
 6 
 7 
 8 
Table 6 Apparent Thermodynamic Functions Relative to Solution Process of Telmisartan (Form A) in 9 
Nine Solvents  10 
Solvent 
Thm* 
(K) 
o
msInH ☆
（kJ∙mol-1
） 
δ1a 
(%
) 
o
msIn
S
△（J∙mol-1 
∙K-1） 
δ2b(
%) 
o
msInG ★(kJ∙m
ol) 
H%
☆
 
TS%
# 
Chloroform 
298.0
0 
8.6 8.4 -12.5 19.8 
12.31    
69.69 
30.31 
Dichlorometha
ne 
297.0
4 
13.4 1.6 -6.2 9.5 
15.19 
87.95 12.05 
Benzene 
305.7
8 
26.2 3.1 15.1 15.6 
21.57 
85.02 14.98 
 26 
 
Methanol 
305.0
6 
23.7 2.4 4.6 33.5 
22.32 
94.41 5.59 
Toluene 
306.1
0 
27.9 3.4 15.8 15.8 
23.04 
85.20 14.80 
Acetone 
301.3
8 
23.9 3.4 2.0  
23.30 
97.48 2.52 
Ethanol 
305.9
4 
29.67 4.0 19.5 20.4 
23.67 
83.22 16.78 
Ethyl acetate 
308.6
4 
25.7 4.0 3.4 54.7 
24.64 
96.10 3.90 
2-Propanol 
313.7
5 
37.6 3.4 38.0 11.2 
25.70 
75.94 24.06 
*
Thm The harmonic mean of the experimental temperatures 1 
☆ o
msInH  The dissolution enthalpy of telmisartan (form A) 2 
△ o
msInS  The dissolution entropy of telmisartan (form A) 3 
★ o
msInG  The Gibbs free energy of the telmisartan (form A)  4 
☆
H% The relative contributions by enthalpy toward the solution process 5 
#
TS%  The relative contributions by entropy toward the solution process 6 
a  random error(uncertainty) of 
o
msInH  δ1=standard error/ |
o
msInH  | 7 
b  random error(uncertainty) of
o
msInS , δ2=standard error/|
o
msInS | 8 
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